The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description
John McGonigle(Imperial College London), J.F.W. Deakin(University of Manchester), Rebecca Elliott(University of Manchester), Louise M. Paterson(Imperial College London), Karen D. Ersche(University of Cambridge), John Suckling(University of Cambridge), Csaba Orbán(Imperial College London), Remy Flechais(Imperial College London), Anna Murphy(University of Manchester), Adam Waldman(Royal Society of Edinburgh), Liam J. Nestor(GlaxoSmithKline (United Kingdom)), Rexford D. Newbould(LivaNova (United Kingdom)), Anne Lingford‐Hughes(Hammersmith Hospital), Trevor W. Robbins(University of Cambridge), Jonathan Nash(Imperial College London), Laurence Reed(Imperial College London), Dana Smith(University of Cambridge), Eleanor Taylor(University of Manchester), David Nutt(Imperial College London)
Cited by 21
Related Papers
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
Neurophysiological Architecture of Functional Magnetic Resonance Images of Human Brain
|Cerebral Cortex|2005|1.4k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
A meta-analysis of sex differences in human brain structure
|Neuroscience & Biobehavioral Reviews|2014|1.2k
Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On
|Annual Review of Psychology|2015|1.2k